Showing 51-60 of 3137 results for "".
Neal Bhatia, MD
https://practicaldermatology.com/topics/practice-management/neal-bhatia-md/22950/Dr. Neal Bhatia is an Associate Professor of Dermatology at Harbor UCLA and is also in private practice in Long Beach, CA. He has published articles on a wide range of topics covering both medical and cosmetic dermatology, and he completed a oneyear appointment on the AAD Board of Directors. Ahead,New Drugs and Therapies in 2025: Dr. Bhatia
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/new-drugs-and-therapies-in-2025-dr-bhatia/32688/Neal Bhatia, MD, discusses the drugs, devices, and more that he and Ted Rosen, MD, presented during "New Drugs and Therapies in 2025" at Maui Derm 2025.Canadian Perspective: Drs. Bhatia, Sapijaszko, and Kaufmann
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/canadian-perspective-drs-bhatia-sapijaszko-and-kaufmann/32695/Neal Bhatia, MD, speaks with Canadian Dermatology Association vice president Mariusz Sapijaszko, MD, FAACS, and former American Academy of Dermatology president Mark Kaufmann, MD, about different perspectives on advocacy in dermatology, including the use of patient stories.DermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dr-bhatia-and-dr-schlesinger-discuss-collaboration-oncologists/26304/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, and Editorial Board member Todd Schlesinger, MD, discuss the importance of collaborating with oncologists on advanced skin cancer cases as immunotherapy technology continues to progress.Terrence Keaney, MD, FAAD
https://practicaldermatology.com/topics/practice-management/terrence-keaney-md-faad/20644/Making the leap to private practice in 2017The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/the-latest-on-systemic-agents-for-psoriasis/29073/The pharmacologic pipeline continues to produce strong options for systemic treatment of psoriasis. Practical Dermatology® spoke with Editorial Board member Jashin J. Wu, MD, FAAD, Founder and CEO of the Dermatology Research and Education Foundation, to discuss the latest treatment considerations wiPhysician Spotlight: J. Matthew Knight, MD, FAAD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-j-matthew-knight-md-faad/20561/Dermatologists must act now to extinguish burnout or risk dire consequences.Crisis Management: Office Operations, Part 1
https://practicaldermatology.com/topics/practice-management/crisis-management-office-operations-part-1/18181/How are primarily cosmetic dermatology practices dealing with shutdowns and preparing for the future? Host Neal Bhatia, MD discusses with Deirdre Hooper, MD, Ashish Bhatia, MD, Kevin Pinski, MD, and Nancy Samolitis, MD.Advanced Systemic Therapeutics
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advanced-systemic-therapeutics/18755/By Seemal R. Desai, MD and Neal Bhatia, MD, FAADFrom updates in infectious disease to hormonal therapies, and off-label uses of biologics, the key to successful treatment is matching mechanisms to disease states. Dr. Bhatia explains.Charles Crutchfield III, MD, FAAD
https://practicaldermatology.com/topics/practice-management/charles-crutchfield-iii-md-faad/21433/